Cancers after Renal Transplantation: Multicenter Experience

Renal transplant recipients are at higher risk of certain tumors such as lymphomas and skin cancers and than the general and dialysis populations. We retrospectively studied the prevalence of tumors in adult renal transplant recipients in four Tunisian centers of transplantation in Tunis, Monsatir a...

Full description

Bibliographic Details
Main Authors: Harzallah Kais, Abderrahim Ezzedine, Chareffedine Khaled, Yeich Soumaya, Belhadj Raoudha, Skhiri Habib, Younsi Fethi, Abdallah Taeib, Abdelletif Achour, Hachicha Jamil, Hmida Jalel, El May Mezri, Khedr Adel, Manaa Jamel
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2008-01-01
Series:Saudi Journal of Kidney Diseases and Transplantation
Subjects:
Online Access:http://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=5;spage=825;epage=830;aulast=Harzallah
_version_ 1818129481224683520
author Harzallah Kais
Abderrahim Ezzedine
Chareffedine Khaled
Yeich Soumaya
Belhadj Raoudha
Skhiri Habib
Younsi Fethi
Abdallah Taeib
Abdelletif Achour
Hachicha Jamil
Hmida Jalel
El May Mezri
Khedr Adel
Manaa Jamel
author_facet Harzallah Kais
Abderrahim Ezzedine
Chareffedine Khaled
Yeich Soumaya
Belhadj Raoudha
Skhiri Habib
Younsi Fethi
Abdallah Taeib
Abdelletif Achour
Hachicha Jamil
Hmida Jalel
El May Mezri
Khedr Adel
Manaa Jamel
author_sort Harzallah Kais
collection DOAJ
description Renal transplant recipients are at higher risk of certain tumors such as lymphomas and skin cancers and than the general and dialysis populations. We retrospectively studied the prevalence of tumors in adult renal transplant recipients in four Tunisian centers of transplantation in Tunis, Monsatir and Sfax from January 1986 to January 2005. The study included 36 patients; 19 men and 17 women with a mean age of 34.6 years (range from 18-54 years). The mean time since dialysis to transplantation was 43 months (6-131months). Maintenance therapy was based on calcineurin inhibitors (CNI) in 86 % of cases, on antimetabolites and corticosteroids in 100 % of cases. Anti-thymoglobulin was administered in a mean course of 12.4 days in 78 % of the patients. Acute rejection occurred in 25 cases and was treated with polyclonal or monoclonal antibodies on 40 % of cases. Incidence of cancer among our population was 7 % and occurred after a mean period of 54 months of transplantation (range from 4-160 months). Eighty three percent of the tumors were solid, and the rest were in the skin. Kaposi sarcoma formed 41.6 % and non-Hodgkin or Hodgkin lymphoma 27.7 % of the solid tumors, while spinocellular carcinoma formed 83% and basocellular carcinoma 17% of the skin tumors. Switching CNI to sirolimus in 8.3% cases was associated with a favorable outcome. Mortality was the outcome in 33.3% of the patients with cancer, while partial or complete regression of cancers was observed in 55.5% cases after decreasing the doses of the immunosuppressive medications. We conclude that post renal transplant cancer is mainly characterized by the predominance of Kaposi sarcoma favored by solar exposure and rigorously induced and maintained immunosuppression. Careful follow-up may results in early inter-vention and decrease mortality.
first_indexed 2024-12-11T07:49:50Z
format Article
id doaj.art-9ae889cc2e4642cbac19962c83b60c0c
institution Directory Open Access Journal
issn 1319-2442
language English
last_indexed 2024-12-11T07:49:50Z
publishDate 2008-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Saudi Journal of Kidney Diseases and Transplantation
spelling doaj.art-9ae889cc2e4642cbac19962c83b60c0c2022-12-22T01:15:22ZengWolters Kluwer Medknow PublicationsSaudi Journal of Kidney Diseases and Transplantation1319-24422008-01-01195825830Cancers after Renal Transplantation: Multicenter ExperienceHarzallah KaisAbderrahim EzzedineChareffedine KhaledYeich SoumayaBelhadj RaoudhaSkhiri HabibYounsi FethiAbdallah TaeibAbdelletif AchourHachicha JamilHmida JalelEl May MezriKhedr AdelManaa JamelRenal transplant recipients are at higher risk of certain tumors such as lymphomas and skin cancers and than the general and dialysis populations. We retrospectively studied the prevalence of tumors in adult renal transplant recipients in four Tunisian centers of transplantation in Tunis, Monsatir and Sfax from January 1986 to January 2005. The study included 36 patients; 19 men and 17 women with a mean age of 34.6 years (range from 18-54 years). The mean time since dialysis to transplantation was 43 months (6-131months). Maintenance therapy was based on calcineurin inhibitors (CNI) in 86 % of cases, on antimetabolites and corticosteroids in 100 % of cases. Anti-thymoglobulin was administered in a mean course of 12.4 days in 78 % of the patients. Acute rejection occurred in 25 cases and was treated with polyclonal or monoclonal antibodies on 40 % of cases. Incidence of cancer among our population was 7 % and occurred after a mean period of 54 months of transplantation (range from 4-160 months). Eighty three percent of the tumors were solid, and the rest were in the skin. Kaposi sarcoma formed 41.6 % and non-Hodgkin or Hodgkin lymphoma 27.7 % of the solid tumors, while spinocellular carcinoma formed 83% and basocellular carcinoma 17% of the skin tumors. Switching CNI to sirolimus in 8.3% cases was associated with a favorable outcome. Mortality was the outcome in 33.3% of the patients with cancer, while partial or complete regression of cancers was observed in 55.5% cases after decreasing the doses of the immunosuppressive medications. We conclude that post renal transplant cancer is mainly characterized by the predominance of Kaposi sarcoma favored by solar exposure and rigorously induced and maintained immunosuppression. Careful follow-up may results in early inter-vention and decrease mortality.http://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=5;spage=825;epage=830;aulast=HarzallahCancerRenalTransplantationImmunosuppressionTumor
spellingShingle Harzallah Kais
Abderrahim Ezzedine
Chareffedine Khaled
Yeich Soumaya
Belhadj Raoudha
Skhiri Habib
Younsi Fethi
Abdallah Taeib
Abdelletif Achour
Hachicha Jamil
Hmida Jalel
El May Mezri
Khedr Adel
Manaa Jamel
Cancers after Renal Transplantation: Multicenter Experience
Saudi Journal of Kidney Diseases and Transplantation
Cancer
Renal
Transplantation
Immunosuppression
Tumor
title Cancers after Renal Transplantation: Multicenter Experience
title_full Cancers after Renal Transplantation: Multicenter Experience
title_fullStr Cancers after Renal Transplantation: Multicenter Experience
title_full_unstemmed Cancers after Renal Transplantation: Multicenter Experience
title_short Cancers after Renal Transplantation: Multicenter Experience
title_sort cancers after renal transplantation multicenter experience
topic Cancer
Renal
Transplantation
Immunosuppression
Tumor
url http://www.sjkdt.org/article.asp?issn=1319-2442;year=2008;volume=19;issue=5;spage=825;epage=830;aulast=Harzallah
work_keys_str_mv AT harzallahkais cancersafterrenaltransplantationmulticenterexperience
AT abderrahimezzedine cancersafterrenaltransplantationmulticenterexperience
AT chareffedinekhaled cancersafterrenaltransplantationmulticenterexperience
AT yeichsoumaya cancersafterrenaltransplantationmulticenterexperience
AT belhadjraoudha cancersafterrenaltransplantationmulticenterexperience
AT skhirihabib cancersafterrenaltransplantationmulticenterexperience
AT younsifethi cancersafterrenaltransplantationmulticenterexperience
AT abdallahtaeib cancersafterrenaltransplantationmulticenterexperience
AT abdelletifachour cancersafterrenaltransplantationmulticenterexperience
AT hachichajamil cancersafterrenaltransplantationmulticenterexperience
AT hmidajalel cancersafterrenaltransplantationmulticenterexperience
AT elmaymezri cancersafterrenaltransplantationmulticenterexperience
AT khedradel cancersafterrenaltransplantationmulticenterexperience
AT manaajamel cancersafterrenaltransplantationmulticenterexperience